EP2888259
Díasepínónafleiður sem eru nytsamlegar við meðhöndlun á brotgjörnum X heilkennum, Parkinsons- eða bakflæðissjúkdómi
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
21.8.2013EP published:
7.3.2018EP application number:
13783671.4
EP translation filed:
14.5.2018Grant published:
15.6.2018EPO information:
European Patent Register
Max expiry date:
20.8.2033Expiry date:
20.8.2021
Title:
DIAZEPINONE DERIVATIVES USEFUL FOR THE TREATMENT OF FRAGILE X SYNDROME, PARKINSONS OR REFLUX DISEASE
Timeline
Today
21.8.2013EP application
7.3.2018EP Publication
14.5.2018Translation submitted
15.6.2018Registration published
20.8.2021Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
BEHNKE, DirkAddress:
Basel, CH
Name:
CARCACHE, DavidAddress:
Basel, CH
Name:
ERTL, PeterAddress:
Basel, CH
Name:
KOLLER, ManuelAddress:
Basel, CH
Name:
ORAIN, DavidAddress:
Basel, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201215033Date:
23.8.2012Country:
GB
Classification
Categories:
C07D 471/04, A61K 31/551, A61P 1/04, A61P 25/16, A61P 25/28
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 5.6.2018
Expires: 20.8.2019
Payer: Árnason Faktor
Number: 7
Paid: 23.7.2019
Expires: 20.8.2020
Payer: Árnason Faktor
Number: 8
Paid: 24.7.2020
Expires: 20.8.2021
Payer: Árnason Faktor ehf.